Milestone Scientific (NYSE:MLSS) Stock Price Down 0.8% – Time to Sell?

Milestone Scientific Inc. (NYSE:MLSS) was down 0.8% during trading on Thursday . The stock traded as low as $0.26 and last traded at $0.2641. Approximately 52,957 shares were traded during mid-day trading, a decline of 80% from the average daily volume of 270,350 shares. The stock had previously closed at $0.2662.

Wall Street Analyst Weigh In

Separately, Benchmark cut their price objective on shares of Milestone Scientific from $1.25 to $1.00 and set a “speculative buy” rating for the company in a research report on Thursday, November 20th. One investment analyst has rated the stock with a Buy rating, According to MarketBeat, Milestone Scientific presently has a consensus rating of “Buy” and an average price target of $1.00.

Milestone Scientific Stock Performance

The stock has a market cap of $20.77 million, a P/E ratio of -3.77 and a beta of 0.97. The stock has a 50-day moving average price of $0.29 and a 200-day moving average price of $0.41.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Milestone Scientific stock. Raymond James Financial Inc. lifted its holdings in shares of Milestone Scientific Inc. (NYSE:MLSS) by 416.7% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 62,000 shares of the company’s stock after purchasing an additional 50,000 shares during the period. Raymond James Financial Inc. owned about 0.08% of Milestone Scientific worth $39,000 as of its most recent filing with the SEC. 5.79% of the stock is owned by institutional investors.

Milestone Scientific Company Profile

Milestone Scientific, Inc, listed on the New York Stock Exchange under the symbol MLSS, is a medical device company specializing in the development and commercialization of computer-controlled injection technologies for local anesthesia and pain management. The company’s proprietary systems are designed to enhance patient comfort, improve clinical outcomes and streamline the administration of anesthetics in dental and medical procedures. Through its precision delivery platforms, Milestone Scientific aims to set a new standard for minimally invasive injections.

At the core of Milestone Scientific’s product portfolio is the Single Tooth Anesthesia (STA) System, which uses Comunication Controlled Local Anesthetic Delivery (CCLAD) technology to provide targeted, atraumatic anesthesia for individual dental roots.